Form D · Pharmaceuticals

FirstString Research, Inc.

Mount Pleasant, SC · CIK 0001719107

Offering snapshot reported Jun 3, 2021 · SEC filing

Reported sold
$26.7M
Offering amount: $30M
Investors reported
Not reported
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Not reported
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 3, 2021Amendment$26,704,818No comparisonNot reportedSEC filing
Apr 21, 2021Initial$23,820,014No comparison17SEC filing
Mar 26, 2019Initial$11,682,912No comparison18SEC filing
Oct 16, 2017Initial$6,575,000No comparison6SEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
Not reported
Finders' fees
Not reported
Form D file number
021-396661

Source: Form D, filed Jun 3, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Tony Bartsh Director
D. Grant Carwile Director
Grant Carwile Director
Elliot Favus Director
Gautam S. Ghatnekar Director, Executive
David Leffell Director
Neal Mc Connell Director
James R. Mc Nab Director
James R. Mc Nab, Jr. Director, Executive
Tina Nova Director
Stephen W. Speer Director
Steven W. Speer Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
300 W. Coleman Blvd. Suite 203
Mount Pleasant, SC, 29464